<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01748656</url>
  </required_header>
  <id_info>
    <org_study_id>12-AGIR-02</org_study_id>
    <nct_id>NCT01748656</nct_id>
  </id_info>
  <brief_title>Target Volume in Noninvasive Positive Pressure Ventilation</brief_title>
  <acronym>CIBLE</acronym>
  <official_title>Comparison of Two Noninvasive Positive Pressure Ventilation Devices Using Target Volume Modes in Obesity Hypoventilation Syndrome (OHS): A Pilot Randomized Crossover Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AGIR à Dom</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ResMed</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>AGIR à Dom</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with OHS are efficiently managed with long term home-based nocturnal noninvasive
      positive pressure ventilation (NIPPV). Several NIPPV devices offer the feature of
      automatically adjusting pressure support (and/or respiratory back-up rate) on the basis of a
      pre-determined &quot;ideal tidal volume&quot; or &quot;ideal ventilation&quot;. However algorithms used to
      achieve these ideal targets are different among different commercialized devices and the
      relative efficacy from an algorithm compared to another remains unknown. The main objective
      is this study is to compare two commercialized NIPPV that have this option
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RESMED Stellar-150 (IVAPS mode)versus PHILIPS-RESPIRONICS A30 (AVAPS-mode).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Nocturnal transcutaneous CO2 pressure (Mean nocturnal PtCO2)</measure>
    <time_frame>1 night</time_frame>
    <description>transcutaneous CO2 pressure is measured overnight. It is a reliable estimation of arterial PaCO2 to monitor nocturnal ventilation in adults with chronic respiratory failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean transcutaneous CO2 pressure during REM Sleep</measure>
    <time_frame>1 Night</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean nocturnal SpO2</measure>
    <time_frame>1 night</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Awake arterial PaCO2 after 1 hour of NIPPV withdrawal</measure>
    <time_frame>After 1 night</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Micro-arousals/hour of sleep</measure>
    <time_frame>1 night</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Quality assess by Visual analogic scale (100mm)</measure>
    <time_frame>1 night</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory residual events detected by NIPPV built-in softwares</measure>
    <time_frame>1 Night</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Obesity Hypoventilation Syndrome</condition>
  <arm_group>
    <arm_group_label>AVAPS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AVAPS mode(BIPAP-A30-PHILIPS-RESPIRONICS)1 night</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IVAPS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IVAPS mode(STELAR 150-RESMED)1 night</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IVAPS</intervention_name>
    <description>IVAPS mode (RESMED Stelar 150) during 1 night</description>
    <arm_group_label>AVAPS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AVAPS</intervention_name>
    <description>AVAPS mode (PHILIPS-RESPIRONICS-A30) during 1 night</description>
    <arm_group_label>IVAPS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with Obesity hypoventilation Syndrome (BMI≥ 30 kg/m2 and diurnal PaCO2 ≥
             45mmHg at diagnosis after exclusion of others causes of hypoventilation)

          -  18 to 75 years old

          -  In stable state but treated by nocturnal NIPPV for more than 3 months and adherent to
             NIPPV (above 4h/night).

        Exclusion Criteria:

          -  patient treated with additional long term Oxygen therapy

          -  Patient previously treated by AVAPS mode or IVAPS mode
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Louis Pepin, MD PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Grenoble France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sleep Laboratory, Grenoble Univeristy Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38900</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2012</study_first_submitted>
  <study_first_submitted_qc>December 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2012</study_first_posted>
  <last_update_submitted>March 13, 2014</last_update_submitted>
  <last_update_submitted_qc>March 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Noninvasive ventilation</keyword>
  <keyword>Obesity Hypoventilation Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Hypoventilation</mesh_term>
    <mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

